Navigation Links
Bush Again Vetoes Embryonic Stem Cell Research Bill

President George W. Bush on Wednesday vetoed for a second time a bill seeking to encourage potentially groundbreaking embryonic stem cell research, saying it violates the sanctity of human life. Risking new criticism from the scientific community, Bush rejected moves by US lawmakers to overturn his earlier prohibition against using federal funds for any research involving human embryo destruction.

It is only the third time in six years as president that he has wielded his veto; the first time was last year when he blocked a similar bill on federal support for embryonic stem cell research. The president, a devout Christian, said that using human embryos for scientific research -- which often involves their destruction -- conflicts with his religious beliefs and he urged scientists to consider other alternatives. "If this legislation became law, it would compel American taxpayers for the first time in our history to support the deliberate destruction of human embryos," Bush said.

"I made it clear to Congress and to the American people that I will not allow our nation to cross this moral line." Embryonic stem cells are primitive cells from early stage embryos capable of developing into almost every tissue of the body. Scientists believe they could be crucial to finding a cure for a number of serious diseases, including Parkinson's and Alzheimer's, diabetes and cancer. But Bush, criticized for holding back promising research after the 2006 veto, offered new support to encouraging alternative stem cell research.

"We're already seeing remarkable advances in science and therapeutic uses of stem cells drawn from adults and children and the blood from umbilical cords with no harm to the donor," he said. "For example, several new studies released earlier this month showed the potential of reprogramming adult cells, such as skin cells, to make them function like embryonic stem cells.

"A few months earlier, scientists dis covered that cells extracted from amniotic fluid and placentas could also provide stem cells that seem to do what embryonic cells can." Bush added: "Our conscious calls us to pursue the possibilities of science in a manner that respects human dignity and upholds our moral values." Immediately after the veto, Democratic Senator Hillary Clinton hit out at Bush for holding back scientific research.

"This is just one example of how the president puts ideology before science, politics before the needs of our families," said Clinton, who is seeking the Democratic nomination for the presidential election next year. Bush also announced directives toward encouraging alternatives to stem cell research reliant on human embryos, directing the Department of Health and Human Services and the National Institutes of Health to ensure than human stem cell lines are "prodcued in ways that do not create, destroy or harm human embryos." Those that follow such orders "will be eligible for federal funding," Bush said.

Researchers have announced their recent success in reprogramming mouse skin cells to mimic the properties of embryonic stem cells, in an advance they hope can be replicated in humans. "By expanding support for nondestructive research methods, this executive order will make it more likely that these exciting advances continue to unfold," the White House said after Bush signed the executive order.

As before, Bush's rejection of the legislation does not prevent private money to be used for embryonic stem cell work. Private foundations and some states have offered funds for research with embryonic stem cells in the wake of Bush's previous veto.


'"/>




Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. Spinal Cord Patients Walk Again
4. New Weapon Against Germs
5. Estrogen Found To Protect the Colon Against Cancer
6. Diet Found To Offer Protection Against Leukemia
7. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
8. WHO Issues Caution Against Bird Flu Epidemic
9. New Supplement Found To Be Effective Against Sunburn
10. Intense Fight Against Polio In India Gets Results
11. Prime Minister Manmohan Against Incentive-Based Population Control
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology: